Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
BRUKINSA Kaps 80 mg Ds 120 Stk
Drug
Brukinsa, Hartkapseln
Morbus Waldenström,
chronisch-lymphatische Leukämie (CLL),
Follikuläres Lymphom
07.16.1. – cytostatics
HAM – Human medicine
KAHA – Capsule, hard
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
2/8/2022
2/7/2027
Dosage strength
Brukinsa 80 mg, Hartkapseln
Morbus Waldenström,
chronisch-lymphatische Leukämie (CLL),
Follikuläres Lymphom
01
Z – approved
Package
8720598340105
No information made available
A/R – Authorised / referenced
120 capsule(s)
001
Z – approved
Declaration
Component
80 mg zanubrutinibum
cellulosum microcristallinum
carmellosum natricum conexum
natrii laurilsulfas
silica colloidalis anhydrica
magnesii stearas
gelatina
E 171
lacca
E 172 (nigrum)
propylenglycolum
1.17 mg natrium
carmellosum natricum conexum
natrii laurilsulfas
silica colloidalis anhydrica
magnesii stearas
gelatina
E 171
lacca
E 172 (nigrum)
propylenglycolum
1.17 mg natrium
Spezialitätenliste***
SL
-
-
4849.60
None
Yes
10%
No
Authorisation holder
7601002995795
BeiGene Switzerland GmbH
Aeschengraben 27
4051 Basel (BS)
Aeschengraben 27
4051 Basel (BS)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.